stockrow
Friday 6 November 2026
Export SOPH’s income statement to Excel — free account
SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024.
- Revenue
- +24.7%
- EPS
- +21.0%
- Free cash flow
- −1.87%
- Total debt
- +1.19%
Quarter to September 2026, against a year earlier
7.09
0.47
+7.10%
Follow SOPH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.08 | 4.34 | 4.94 | 7.88 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(38.77) | (23.29) | (55.39) | (75.60) | |
P/B ratio |
6.69 | 7.71 | 5.13 | 10.47 | |
Price to Tangible BV |
28.03 | 35.70 | 9.07 | 21.99 | |
EV/Sales |
3.81 | 4.14 | 4.27 | 7.39 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(8.20) | (8.35) | (9.26) | (16.64) | |
EV/FCF |
(8.04) | (8.04) | (8.91) | (16.17) | |
Quick Ratio |
1.69 | 1.71 | 2.38 | 2.01 | |
Current Ratio |
1.96 | 2.06 | 2.69 | 2.29 | |
Net Debt/EBITDA |
1.40 | 1.21 | 3.48 | 3.03 | |
Debt/Assets |
29.28% | 30.47% | 24.20% | 26.06% | |
Debt/Equity |
1.01 | 1.05 | 0.58 | 0.70 | |
Asset Turnover |
0.49 | 0.53 | 0.46 | 0.52 | |
Operating CF/Net income |
0.42 | 0.78 | 0.34 | 0.47 | |
Capex/Depreciation |
(0.09) | (0.33) | (0.05) | 0.10 | |
Interest Coverage |
(11.07) | (10.37) | (12.38) | (11.02) | |
Research and Development Expense of Revenue |
39.33% | 43.62% | 37.46% | 34.18% | |
Selling, General and Administrative Expense of Revenue |
113.57% | 104.08% | 113.20% | 104.93% | |
Intangible Assets out of Total Assets |
0.22 | 0.23 | 0.18 | 0.19 | |
Share Based Compensation of Revenue |
17.82% | 15.28% | 19.27% | 18.77% | |
Graham Net Nets |
(0.05) | (0.04) | 0.05 | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(25.12%) | (23.90%) | (19.93%) | (12.97%) | |
Free Cash Flow Yield |
(11.61%) | (11.87%) | (9.69%) | (5.81%) | |
Revenue per Share |
0.32 | 0.30 | 0.32 | 0.28 | |
Operating CF per Share |
(0.12) | (0.21) | (0.10) | (0.11) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.12) | (0.23) | (0.11) | (0.11) | |
Cash per Share |
1.04 | 0.92 | 1.46 | 1.10 | |
Shareholders Equity per Share |
0.70 | 0.64 | 1.13 | 0.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.70 | 0.64 | 1.13 | 0.80 | |
Free Cash Flow |
(8.36) | (16.03) | (7.84) | (9.20) | |
Working Capital |
48.55 | 49.22 | 86.21 | 70.71 | |
Capital Expenditures |
(0.22) | (0.91) | (0.15) | 0.27 | |
Net Current Asset Value |
(16.81) | (15.50) | 22.05 | 9.33 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.04 | 0.01 | (0.01) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
11.22 | 12.50 | 11.81 | 12.59 | |
Average Payables |
7.09 | 8.64 | 9.82 | 8.17 | |
Average Inventory |
6.11 | 6.07 | 6.65 | 6.92 | |
Average Assets |
159.17 | 151.86 | 187.99 | 174.09 | |
Average Common Equity |
71.82 | 65.65 | 79.91 | 64.56 |
Columns are period end dates · fundamentals updated 5 Nov 2026